Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jan 7, 2020; 26(1): 70-85
Published online Jan 7, 2020. doi: 10.3748/wjg.v26.i1.70
Table 4 Factors associated with upper gastrointestinal cancer detection the first year after baseline colonoscopy, n (%)
Upper gastrointestinal cancerOdds ratio (95 %CI)1Odds ratio (95 %CI)2
Sex
Female (n = 1432)10 (0.7)1
Male (n = 1277)12 (0.9)1.3 (0.6-3.1)
Age
< 70 yr (n = 1757)8 (0.5)11
≥ 70 yr (n = 952)14 (1.5)3.3 (1.4-7.8)2.7 (1.1-7.0)
Primary healthcare referral
No (n = 1936)19 (1.0)1
Yes (n = 617)3 (0.5)0.5 (0.1-1.7)
Rectal bleeding
No (n = 1319)16 (1.2)1
Yes (n = 1234)6 (0.5)0.4 (0.1-1.0)
Change of bowel habit
No (n = 1282)12 (0.9)1
Adequate (n = 1271)10 (0.8)0.8 (0.4-1.9)
Anaemia3
No (n = 2077)13 (0.6)11
Yes (n = 191)8 (4.2)6.9 (2.8-17.0)5.6 (2.2-13.9)
Abdominal pain
No (n = 1319)12 (1.1)1
Yes (n = 1234)5 (0.7)0.6 (0.2-1.7)
Weight loss
No (n = 1462)12 (0.8)1
Yes (n = 391)5 (1.3)1.5 (0.5-4.4)
Faecal immunochemical test
< 10 µg/g (n = 1979)14 (0.7)1
≥ 10 µg/g (n = 730)8 (1.1%)1.5 (0.6-3.7)
Benign anorectal lesion
No (n = 961)7 (0.7)1
Yes (n = 756)6 (0.8)1.1 (0.4-3.2)
Significant colonic lesion4
No (n = 2216)16 (0.7)1
Yes (n = 480)6 (1.3)(0.7-4.5)
Advanced adenoma5
No (n = 2968)16 (0.7)1
Yes (n = 337)6 (1.8)2.5 (1.0-6.4)

  • Citation: Pin-Vieito N, Iglesias MJ, Remedios D, Rodríguez-Alonso L, Rodriguez-Moranta F, Álvarez-Sánchez V, Fernández-Bañares F, Boadas J, Martínez-Bauer E, Campo R, Bujanda L, Ferrandez Á, Piñol V, Rodríguez-Alcalde D, Guardiola J, Cubiella J, on behalf of the COLONPREDICT study investigators. Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test. World J Gastroenterol 2020; 26(1): 70-85
  • URL: https://www.wjgnet.com/1007-9327/full/v26/i1/70.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v26.i1.70